Loading...
Phibro Animal Health Corporation
PAHC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$28.16
$-1.02(-3.48%)
Phibro Animal Health Corporation (PAHC) Financial Performance & Income Statement Overview
Review Phibro Animal Health Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
4.07%
↑ 4.07%
Operating Income Growth
-25.79%
↓ 25.79%
Net Income Growth
-92.59%
↓ 92.59%
Operating Cash Flow Growth
558.11%
↑ 558.11%
Operating Margin
7.51%
↑ 7.51%
Gross Margin
31.64%
↑ 31.64%
Net Profit Margin
2.67%
↑ 2.67%
ROE
12.37%
↑ 12.37%
ROIC
8.51%
↑ 8.51%
Phibro Animal Health Corporation (PAHC) Income Statement & Financial Overview
Review Phibro Animal Health Corporation's (PAHC) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $309.26M | $260.43M | $273.16M | $263.22M |
| Cost of Revenue | $207.39M | $176.94M | $186.39M | $184.35M |
| Gross Profit | $101.87M | $83.50M | $86.78M | $78.87M |
| Gross Profit Ratio | $0.33 | $0.32 | $0.32 | $0.30 |
| R&D Expenses | $0.00 | $0.00 | $29.19M | $0.00 |
| SG&A Expenses | $76.34M | $65.80M | $74.14M | $58.68M |
| Operating Expenses | $76.34M | $65.80M | $74.14M | $58.68M |
| Total Costs & Expenses | $283.73M | $242.73M | $260.53M | $243.03M |
| Interest Income | $168000.00 | $531000.00 | $1.26M | $1.07M |
| Interest Expense | $9.16M | $8.17M | $5.74M | $5.38M |
| Depreciation & Amortization | $11.57M | $9.004M | $9.20M | $9.20M |
| EBITDA | $25.53M | $26.80M | $25.25M | $29.84M |
| EBITDA Ratio | $0.08 | $0.10 | $0.09 | $0.11 |
| Operating Income | $25.53M | $17.70M | $12.64M | $20.19M |
| Operating Income Ratio | $0.08 | $0.07 | $0.05 | $0.08 |
| Other Income/Expenses (Net) | -$20.70M | -$8.08M | -$6.23M | -$7.002M |
| Income Before Tax | $4.84M | $9.62M | $6.41M | $12.92M |
| Income Before Tax Ratio | $0.02 | $0.04 | $0.02 | $0.05 |
| Income Tax Expense | $1.65M | $2.65M | $5.66M | $4.52M |
| Net Income | $3.19M | $6.97M | $752000.00 | $8.40M |
| Net Income Ratio | $0.01 | $0.03 | $0.003 | $0.03 |
| EPS | $0.08 | $0.17 | $0.02 | $0.21 |
| Diluted EPS | $0.08 | $0.17 | $0.02 | $0.21 |
| Weighted Avg Shares Outstanding | $40.50M | $40.50M | $40.50M | $40.50M |
| Weighted Avg Shares Outstanding (Diluted) | $40.72M | $40.58M | $40.60M | $40.52M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan